These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27153815)

  • 1. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.
    Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y
    Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
    Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful pregnancy outcome in a patient with severe chylomicronemia due to compound heterozygosity for mutant lipoprotein lipase.
    Al-Shali K; Wang J; Fellows F; Huff MW; Wolfe BM; Hegele RA
    Clin Biochem; 2002 Mar; 35(2):125-30. PubMed ID: 11983347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia.
    Rabacchi C; Pisciotta L; Cefalù AB; Noto D; Fresa R; Tarugi P; Averna M; Bertolini S; Calandra S
    Atherosclerosis; 2015 Jul; 241(1):79-86. PubMed ID: 25966443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional characterization of familial chylomicronemia syndrome.
    Teramoto R; Tada H; Kawashiri MA; Nohara A; Nakahashi T; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2018 Feb; 269():272-278. PubMed ID: 29153744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
    J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature.
    Huang Y; Qin Y; Liao L; Lin F
    Clin Chim Acta; 2022 Dec; 537():112-117. PubMed ID: 36252692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists.
    Falko JM
    Endocr Pract; 2018 Aug; 24(8):756-763. PubMed ID: 30183397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1.
    Ahmad Z; Wilson DP
    J Clin Lipidol; 2014; 8(6):635-639. PubMed ID: 25499947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome.
    Rioja J; Ariza MJ; Benítez-Toledo MJ; Espíldora-Hernández J; Coca-Prieto I; Arrobas-Velilla T; Camacho A; Olivecrona G; Sánchez-Chaparro MÁ; Valdivielso P
    J Clin Lipidol; 2023; 17(2):272-280. PubMed ID: 36813655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society.
    Ariza MJ; Rioja J; Ibarretxe D; Camacho A; Díaz-Díaz JL; Mangas A; Carbayo-Herencia JA; Ruiz-Ocaña P; Lamíquiz-Moneo I; Mosquera D; Sáenz P; Masana L; Muñiz-Grijalvo O; Pérez-Calahorra S; Valdivielso P;
    J Clin Lipidol; 2018; 12(6):1482-1492.e3. PubMed ID: 30150141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two novel mutations of the LPL gene in two Chinese family cases with familial chylomicronemia syndrome.
    Wang M; Zhou Y; He X; Deng C; Liu X; Li J; Zhou L; Li Y; Zhang Y; Liu H; Li L
    Clin Chim Acta; 2021 Oct; 521():264-271. PubMed ID: 34324844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E; Moulin P; Parhofer KG; Rebours V; Löhr JM; Averna M
    Atheroscler Suppl; 2017 Jan; 23():1-7. PubMed ID: 27998715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
    Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
    BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
    Overgaard M; Brasen CL; Svaneby D; Feddersen S; Nybo M
    Ann Clin Biochem; 2013 Jul; 50(Pt 4):374-9. PubMed ID: 23761384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
    Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
    Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online.
    Evans D; Wendt D; Ahle S; Guerra A; Beisiegel U
    Hum Mutat; 1998; 12(3):217. PubMed ID: 10660334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment.
    Stefanutti C; Gozzer M; Pisciotta L; D'Eufemia P; Bosco G; Morozzi C; Papadia F; Shafii M; Di Giacomo S; Bertolini S
    Atheroscler Suppl; 2013 Jan; 14(1):73-6. PubMed ID: 23357145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations.
    Vigna GB; Citroni N; Tarugi P; Fellin R
    J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.